Lombard Odier Asset Management (USA)’s Gilead Sciences GILD Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,958	Closed	-$258K	–	198
2026 Q1	$273K	Buy	+1,958	New	+$274K	0.03%	207
2024 Q2	–	Sell	-20,549	Closed	-$1.37M	–	304
2024 Q1	$1.51M	Buy	+20,549	New	+$1.58M	0.04%	159
2020 Q4	–	Sell	-10,366	Closed	-$625K	–	286
2020 Q3	$655K	Sell	10,366 -24,634	-70%	-$1.71M	0.04%	202
2020 Q2	$2.69M	Buy	+35,000	New	+$2.68M	0.19%	129
2020 Q1	–	Sell	-50,000	Closed	-$3.45M	–	214
2019 Q4	$3.25M	Buy	50,000 +5,000	+11%	+$326K	0.29%	100
2019 Q3	$2.85M	Buy	+45,000	New	+$2.94M	0.27%	102
2015 Q4	–	Sell	-20,000	Closed	-$1.96M	–	171
2015 Q3	$1.96M	Buy	+20,000	New	+$2.22M	0.17%	139
2013 Q3	–	Sell	-50,000	Closed	-$2.56M	–	171
2013 Q2	$2.56M	Buy	+50,000	New	+$2.61M	0.14%	114

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s GILD Position: Q2 2026 in Review

Lombard Odier Asset Management (USA) sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,958 shares — an estimated $258K sold.

Lombard Odier Asset Management (USA) first reported a position in GILD in Q2 2013 and held it in 8 quarters. The position peaked at $3.25M in Q4 2019. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Lombard Odier Asset Management (USA) reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 1,958 Gilead Sciences shares in Q2 2026, an estimated $258K.
Lombard Odier Asset Management (USA) first reported a position in Gilead Sciences in Q2 2013 and held it in 8 quarters.
Lombard Odier Asset Management (USA)'s Gilead Sciences position peaked at $3.25M in Q4 2019.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2026, filed 14 Aug 2026.